Table 1. Baseline demographics, duration of disease and therapy of patients.
UC N = 49 |
Active UC N = 19 |
Non-UC N = 23 |
|
---|---|---|---|
Age (years) | |||
Mean (SD) | 38·5 (15·6) | 36.13 | 36·7 (15·9) |
Range | 24–74 | 19–71 | 21–59 |
Gender (% male) | 46 | 42 | 42 |
Duration of UC (years) | |||
Mean (SD) | 11·6 (9·53) | 11.46 (10.97) | |
Range | 1–40 | 1–39 | |
SCCAI | |||
Mean (SD) | 3·04 (2·79) | 6.42 (2.19) | |
Range | 0–13 | 5–13 | |
Treatment (current) | |||
TNFα-blocker | 20 | 6 | |
Glucocorticoids | 13 | 8 | |
Mesalazine | 26 | 9 | |
Immuno-suppressive | 6 | 3 | |
No | 10 | 3 | |
Atopic Dermatitis | 3 |